Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |